PCI Pharma Services has completed its acquisition of Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO and subsidiary of Japan-based Ajinomoto Co. Inc. For PCI, the acquisition is a cornerstone of a multi-year investment strategy spanning facilities in the United States and Europe. In the United States, Althea’s assets combine with PCI’s existing sterile fill-finish and advanced drug delivery operations to form a large-scale manufacturing hub in San Diego, complete with large-scale ...